Chilean scientists develop the first vaccine against respiratory syncytial virus

The first vaccine against respiratory syncytial virus was developed by Chilean scientists, who expect that this vaccine will available to general public in next four or five years. MIII Director Dr. Alexis Kalergis expresses the reach of this advance.

Read the whole article published in EMOL and  biobiochile.cl